MANCINI, NICASIO
 Distribuzione geografica
Continente #
EU - Europa 2.614
NA - Nord America 1.851
AS - Asia 322
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
SA - Sud America 1
Totale 4.797
Nazione #
IT - Italia 2.077
US - Stati Uniti d'America 1.816
IE - Irlanda 152
SG - Singapore 150
UA - Ucraina 84
DE - Germania 73
TR - Turchia 60
SE - Svezia 57
GB - Regno Unito 55
FI - Finlandia 53
CN - Cina 45
CA - Canada 33
VN - Vietnam 24
JP - Giappone 18
FR - Francia 16
AT - Austria 14
IN - India 14
BE - Belgio 12
HK - Hong Kong 9
AU - Australia 5
CH - Svizzera 5
LT - Lituania 5
NL - Olanda 3
EU - Europa 2
PL - Polonia 2
RU - Federazione Russa 2
BR - Brasile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
IR - Iran 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 4.797
Città #
Milan 1.340
Ashburn 214
Boardman 208
Chicago 163
Dublin 148
Singapore 143
Fairfield 141
Rome 107
Chandler 94
Varese 86
Jacksonville 72
Seattle 71
Woodbridge 55
Como 54
Ogden 49
Houston 46
Los Angeles 46
Wilmington 45
Ann Arbor 41
Washington 41
Dallas 37
Nyköping 35
Santa Clara 34
Cambridge 32
Princeton 30
Toronto 28
Magnago 26
Izmir 25
Dearborn 23
Frankfurt am Main 19
San Diego 17
Tokyo 16
Vienna 14
London 13
Assago 12
Brussels 12
West Jordan 12
Helsinki 11
Pune 11
Lappeenranta 10
Munich 10
Dong Ket 8
Hong Kong 8
Verona 8
Berlin 7
Hounslow 6
New York 6
Chiswick 5
Kilburn 5
Ottawa 5
Cernusco sul Naviglio 4
Nanjing 4
Paris 4
Acton 3
Gorgonzola 3
Jinan 3
Norwalk 3
Phoenix 3
Romola 3
Shanghai 3
Turin 3
Amsterdam 2
Arezzo 2
Barnet 2
Chennai 2
Clyde North 2
Columbia 2
Desio 2
Giussano 2
Hefei 2
Kunming 2
Lugano 2
Mountain View 2
Naples 2
Pescara 2
Pognana Lario 2
Prescot 2
Sarno 2
Shenyang 2
Southwark 2
Tallahassee 2
Teramo 2
Treviglio 2
Vedano al Lambro 2
Velletri 2
Xi'an 2
York 2
Örebro 2
Agrate Conturbia 1
Auckland 1
Bacoor 1
Baoding 1
Belgrade 1
Bouxieres-aux-Dames 1
Brno 1
Castleford 1
Central 1
Cesena 1
Changsha 1
Chengdu 1
Totale 3.751
Nome #
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques. 144
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV). 137
Coronaviridae and SARS-associated coronavirus strain HSR1. 135
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction. 129
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site. 127
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection. 124
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient. 117
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. 95
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 91
Phage display for the production of human monoclonal antibodies against human pathogens. 88
Humoral immune response against hepatitis C virus. 83
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV). 81
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments. 80
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 68
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy 60
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice 57
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples 55
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 53
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 51
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 46
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 45
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 44
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 43
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 43
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 42
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 42
A biologically-validated HCV E1E2 heterodimer structural model 41
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference 41
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 40
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital 40
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 39
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 39
Viral respiratory pathogens and lung Injury 39
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 38
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals 38
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing 38
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 38
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 38
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 37
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 37
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 37
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 37
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 37
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study 37
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 37
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 36
Risks of "blind" automated identification systems in medical microbiology 36
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 36
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 35
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 35
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 35
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 35
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay 34
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 34
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2 34
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 34
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 34
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies 34
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 33
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes 33
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients 33
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey 33
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections 33
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 32
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 32
Interferon-β-1a inhibition of severe acute respiratory syndrome–Coronavirus 2 in vitro when administered after virus infection 32
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey 32
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 31
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 31
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro 31
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence 31
Type III interferons disrupt the lung epithelial barrier upon viral recognition 31
The interferon landscape along the respiratory tract impacts the severity of COVID-19 31
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 31
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 31
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 30
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype 30
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 29
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII) 29
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 28
Answer to photo quiz: Streptococcus pneumoniae 26
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 26
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms 26
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 25
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation 23
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 22
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy 22
Dual-domain reporter approach for multiplex identification of major SARS-CoV-2 variants of concern in a microarray-based assay 22
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 22
Role and potential therapeutic use of antibodies against herpetic infections 22
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 21
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 21
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series 21
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 21
Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia 21
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 20
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role 20
A closer look at prion strains: characterization and important implications 19
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- 19
Monoclonal Antibodies and Flaviviruses: a Possible Option? 19
Totale 4.385
Categoria #
all - tutte 38.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020179 0 0 0 0 16 29 40 34 20 20 2 18
2020/2021185 3 20 4 22 5 20 18 17 29 6 16 25
2021/2022219 11 43 20 17 4 0 35 21 16 21 11 20
2022/2023704 19 7 13 34 34 52 0 39 267 129 35 75
2023/20242.699 371 395 336 500 572 254 23 55 79 66 12 36
2024/2025949 24 58 629 141 97 0 0 0 0 0 0 0
Totale 5.267